Consensus Ventas, Inc. Deutsche Boerse AG

Stocks

VEN

US92276F1003

Specialized REITs

Market Closed - Deutsche Boerse AG 04:02:05 16/09/26 pm AEST			5-day change	1st Jan Change
76.48 ^EUR	-0.18%		-0.57%	+13.61%

16/09	Ventas, Inc. Announces Appointment of Laurida Sayed as Senior Vice President, Chief Accounting Officer and Controller, Effective on or About October 5, 2026	CI
15/09	Ventas Keeps Quarterly Dividend at $0.52 a Share, Payable Oct. 15 to Shareholders of Record Sept. 30	MT

1101160a06e3d0dfa9f13.lI1cMibKqKnojcYrwt-9QdvB69iC0-dTEYN4T3UYtDI.3-UFXmeNx_jF649vhov-cp-U2e6054Qle_YKODhT1nPxvDN8dKef4K3krQ~f4cb3af5291fcc8bd800b104ffa3d4c8

Analysts' recommendations: Ventas, Inc.

02/09	Scotiabank Adjusts Price Target on Ventas to $95 From $93, Maintains Sector Perform Rating	MT
02/09	JPMorgan Adjusts Price Target on Ventas to $104 From $94, Maintains Overweight Rating	MT
01/09	Wells Fargo Adjusts Price Target on Ventas to $104 From $96, Maintains Overweight Rating	MT
31/08	Barclays Adjusts Price Target on Ventas to $102 From $99, Keeps Equalweight Rating	MT
15/08	Ventas Earnings Growth Supported by Strong Senior Housing Trends, RBC Says	MT
14/08	RBC Adjusts Price Target on Ventas to $99 From $98, Maintains Outperform Rating	MT
12/08	Jefferies Adjusts Price Target on Ventas to $102 From $109, Maintains Buy Rating	MT
11/08	BMO Capital Adjusts Price Target on Ventas to $107 From $105, Keeps Outperform Rating	MT
06/08	Argus Research Adjusts Ventas Price Target to $98 From $92	MT
04/08	Citigroup Adjusts Price Target on Ventas to $110 From $100, Maintains Buy Rating	MT
04/08	Evercore ISI Adjusts Price Target on Ventas to $101 From $96, Maintains Outperform Rating	MT
03/08	BMO Capital Adjusts Price Target on Ventas to $105 From $100, Maintains Outperform Rating	MT
31/07	BNP Paribas Adjusts Ventas Price Target to $110 From $93, Maintains Outperform Rating	MT
24/07	Goldman Sachs Adjusts Price Target on Ventas to $114 From $110, Maintains Buy Rating	MT
22/07	Mizuho Adjusts Price Target on Ventas to $104 From $98, Maintains Outperform Rating	MT
16/07	Jefferies Adjusts Price Target on Ventas to $109 From $100, Maintains Buy Rating	MT
11/07	Scotiabank Adjusts Price Target on Ventas to $93 From $88	MT
01/07	Evercore ISI Adjusts Ventas Price Target to $96 From $95, Maintains Outperform Rating	MT
18/06	Scotiabank Adjusts Price Target on Ventas to $88 From $95, Maintains Sector Perform Rating	MT
16/06	Deutsche Bank Lifts Price Target on Ventas to $100 From $95, Keeps Buy Rating	MT
01/06	Wells Fargo Adjusts Price Target on Ventas to $96 From $93, Maintains Overweight Rating	MT
26/05	BofA Adjusts Price Target on Ventas to $110 From $102	MT
22/05	Baird Adjusts Price Target on Ventas to $98 From $97, Maintains Outperform Rating	MT
22/05	Mizuho Adjusts Price Target on Ventas to $98 From $94, Maintains Outperform Rating	MT
21/05	Scotiabank Adjusts Price Target on Ventas to $95 From $93, Maintains Sector Perform Rating	MT

More recommendations

Healthcare REITs

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	WELLTOWER INC.					+12.66%
	VENTAS, INC.					+15.02%
	OMEGA HEALTHCARE INVESTORS, INC.					+10.1%
	HEALTHPEAK PROPERTIES, INC.					+14.09%
	AMERICAN HEALTHCARE REIT, INC.					+21.3%
	CARETRUST REIT, INC.					+17.53%
	HEALTHCARE REALTY TRUST INCORPORATED					+14.83%
	AEDIFICA					+25.26%
	SABRA HEALTH CARE REIT, INC.					+12.41%
	Average					+15.91%
	Weighted average by Cap.					+13.85%